Safe Acid Reflux Medications During Pregnancy
MHRA-Approved Pregnancy Categories
The Medicines and Healthcare products Regulatory Agency (MHRA) classifies acid reflux medications based on pregnancy safety data. Omeprazole, available through EverydayMeds as both generic 20mg capsules and branded Losec MUPS, is classified as pregnancy category B, indicating no increased risk of birth defects in human studies. Famotidine tablets represent another safe option, belonging to the H2 receptor antagonist class with extensive pregnancy safety data spanning decades of clinical use.
First-Line Treatment Approaches
Healthcare providers typically recommend a stepped approach to managing pregnancy-related acid reflux. Initial management includes dietary modifications, eating smaller frequent meals, and avoiding trigger foods such as spicy, fatty, or acidic items. When these measures prove insufficient, antacids containing calcium carbonate or magnesium may provide relief. However, persistent symptoms often require prescription intervention with proton pump inhibitors or H2 blockers available from EverydayMeds.
Prescription Treatment Options
When lifestyle modifications prove inadequate, prescription medications may be necessary. Omeprazole 20mg capsules represent the most commonly prescribed PPI during pregnancy, effectively reducing gastric acid production by blocking the proton pump system. Lansoprazole 15mg capsules offer an alternative PPI option, whilst famotidine tablets provide H2 receptor antagonism for women who may not tolerate PPIs. EverydayMeds stocks these pregnancy-appropriate treatments following UK prescribing guidelines.
Dosage and Duration Considerations
Pregnancy dosing typically mirrors standard adult recommendations, with omeprazole 20mg once daily representing the usual starting dose. Treatment duration should be minimised to the shortest effective period, often 2-4 weeks for symptom relief. Some women may require continued treatment throughout pregnancy, particularly during the third trimester when uterine growth increases abdominal pressure. Healthcare providers may adjust dosing based on symptom severity and individual response.
